ReviewCVIR endovascular2026
Evolving strategies in pulmonary arteriovenous malformation embolization.
Review in CVIR endovascular, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Pulmonary arteriovenous malformations (PAVMs) cause right-to-left shunting with risks of hypoxemia and paradoxical embolization. Endovascular embolization is the standard treatment, but long-term durability depends on anatomy, flow characteristics, device selection, embolization strategy, and follow-up definitions. This narrative review synthesizes contemporary evidence on embolic devices-including coils, vascular plugs, microvascular plugs, low-profile braided occluders, and liquid embolics-along with adjunctive techniques such as balloon occlusion, nidus-directed embolization, and cone-beam CT guidance. Available retrospective data suggest that plug-based strategies may be associated with lower persistence in anatomically suitable lesions, whereas coils, liquid embolics, and hybrid approaches remain important for complex, recurrent, or anatomically constrained lesions. Emphasis is placed on an anatomy-, flow-, and imaging-based decision framework, cautious interpretation of heterogeneous evidence, and structured long-term surveillance to minimize persistence and optimize clinical outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.